Schweitzer D H, Boxman I L, Löwik C W, van Krieken J H, Weissglas M G, Baatenburg de Jong R J, Papapoulos S E
Department of Endocrinology, University Hospital Leiden, The Netherlands.
J Clin Pathol. 1995 Oct;48(10):896-900. doi: 10.1136/jcp.48.10.896.
To determine the expression of parathyroid hormone related protein (PTHrP) and interleukin-6 (IL-6) mRNAs and their possible relation in malignant tumours, derived from patients with and without hypercalcaemia, commonly associated with humoral hypercalcaemia of malignancy.
PTHrP and IL-6 mRNA expression was studied by northern blot analysis in tumour specimens from 13 consecutive patients. Six patients (two with hypercalcaemia) had squamous cell carcinomas of the larynx and seven (one with hypercalcaemia) had renal cell carcinomas.
There was no relation between the histological features of the tumours and the expression of either PTHrP or IL-6 mRNAs. PTHrP mRNA was detected in all squamous cell carcinomas, expression being highest in the two patients with hypercalcaemia. In the renal cell carcinomas PTHrP mRNA was expressed only in the patient with hypercalcaemia. IL-6 mRNA was detected in nearly all tumours studied but there was no apparent relation between its expression and that of PTHrP mRNA or serum calcium concentrations.
PTHrP mRNA expression is increased in patients with hypercalcaemia but is not related to IL-6 mRNA expression. The results suggest a quantitative relation between PTHrP gene expression and hypercalcaemia, and imply that different mechanisms account for this expression in squamous and renal cell carcinomas.
确定甲状旁腺激素相关蛋白(PTHrP)和白细胞介素-6(IL-6)mRNA的表达及其在恶性肿瘤中的可能关系,这些肿瘤来源于伴有或不伴有高钙血症的患者,通常与恶性肿瘤体液性高钙血症相关。
通过Northern印迹分析研究了13例连续患者肿瘤标本中PTHrP和IL-6 mRNA的表达。6例患者(2例有高钙血症)患有喉鳞状细胞癌,7例(1例有高钙血症)患有肾细胞癌。
肿瘤的组织学特征与PTHrP或IL-6 mRNA的表达之间没有关系。在所有鳞状细胞癌中均检测到PTHrP mRNA,在2例高钙血症患者中表达最高。在肾细胞癌中,PTHrP mRNA仅在高钙血症患者中表达。在几乎所有研究的肿瘤中均检测到IL-6 mRNA,但其表达与PTHrP mRNA的表达或血清钙浓度之间没有明显关系。
高钙血症患者中PTHrP mRNA表达增加,但与IL-6 mRNA表达无关。结果表明PTHrP基因表达与高钙血症之间存在定量关系,并暗示鳞状细胞癌和肾细胞癌中这种表达的机制不同。